SCHEMBL9937599

SCHEMBL9937599

Cc1ccccc1C(=O)Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 11/20 0.53
MEN1 O00255 6/20 0.53
NPC1 O15118 1/20 0.53
CASP3 P42574 1/20 0.53
SENP8 Q96LD8 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
MAPT P10636 6/20 0.40
LMNA P02545 1/20 0.40
ESR1 P03372 5/20 0.39
ESR2 Q92731 4/20 0.39
HTT P42858 1/20 0.38
PKM P14618 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
NPBWR1 P48145 1/20 0.35
F12 P00748 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937518 0.88 KMT2A (0.38) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL23199773 0.88 HSD17B10 (0.44) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL9937557 0.86 MAPT (0.41) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL9937653 0.85 KMT2A (0.37) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL669403 0.84 KMT2A (0.55) KMT2AMEN1MAPTESR1PKM
SCHEMBL668901 0.81 CA12 (0.41) KMT2AMEN1MAPTLMNAPKM
SCHEMBL996026 0.81 CA12 (0.41) KMT2AMEN1MAPTLMNAPKM
SCHEMBL31499303 0.80 KMT2A (0.67) KMT2AMEN1NPC1CASP3SENP8
SCHEMBL9938274 0.78 ELANE (0.38) LMNATDP1ALDH1A1
SCHEMBL9938547 0.78 KDM4E (0.40) KMT2ANPC1MAPTLMNAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed